Clinical Trial Update: 68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for 68Ga-FAP-RGD PET/CT focusing on dosimetry and preliminary translational studies across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor

Drugs mentioned

• 68Ga-FAP-RGD PET/CT

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Tumor | Phase 1, Phase 2 | Status: UNKNOWN